|
[1]VILLA E,MOLES A,FERRETTI I,et al.Natural history of inoperable hepatocellular carcinoma:estrogen receptors'status in the tumor is the strongest prognostic factor for survival[J].Hepatology,2000,32(2):233-238.
|
|
[2]TAWADA A,CHIBA T,OOKA Y,et al.Efficacy of transarterial chemoembolization targeting portal vein tumor thrombus in patients with hepatocellular carcinoma[J].Anticancer Res,2014,34(8):4231-4238.
|
|
[3]BRUIX J,SHERMAN M.Management of hepatocellular carcinoma:an update[J].Hepatology,2011,53(3):1020-1022.
|
|
[4]European Association for the Study of the Liver,European Organisation for Research and Treatment of Cancer.EASL-EORTC clinical practice guidelines:management of hepatocellular carcinoma[J].J Hepatol,2012,56(4):908-943.
|
|
[5]OMATA M,LESMANA LA,TATEISHI R,et al.Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma[J].Hepatol Int,2010,4(2):439-474.
|
|
[6]CHENG AL,KANG YK,CHEN Z,et al.Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma:a phase III randomised,double-blind,placebo-controlled trial[J].Lancet Oncol,2009,10(1):25-34.
|
|
[7] LLOVET JM,RICCI S,MAZZAFERRO V,et al.Sorafenib in advanced hepatocellular carcinoma[J].N Engl J Med,2008,359(4):378-390.
|
|
[8]SONGA ZZ,HUANG M,JIANGTA,et al.Diagnosis of portal vein thrombosis discontinued with liver tumors in patients with liver cirrhosis and tumors by contrast-enhanced US:a pilot study[J].Eur J Radio,2010,75(2):185-188.
|
|
[9] LUO J,GUO RP,LAI EC,et al.Transarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein tumor thrombosis:a prospective comparative study[J].Ann Surg Oncol,2011,18(2):413-420.
|
|
[10]LAU WY,SANGRO B,CHEN PJ,et al.Treatment for hepatocellular carcinoma with portal vein tumor thrombosis:the emerging role for radioembolization using yttrium-90[J].Oncology,2013,84(5):311-318.
|
|
[11] ZHU K,CHEN J,LAI L,et al.Hepatocellular carcinoma with portal vein tumor thrombus:treatment with transarterial chemoembolization combined with sorafenib-a retrospective controlled study[J].Radiology,2014,272(1):284-293.
|
|
[12]KUDO M,IZUMI N,KOKUDO N,et al.Management of hepatocellular carcinoma in Japan:consensus-based clinical practice guidelines proposed by the Japan Society of Hepatology(JSH)2010 updated version[J].Dig Dis,2011,29(3):339-364.
|
|
[13]SHI J,LAI E,LI N,et al.Surgical treatment of hepatocellular carcinoma with portal vein tumor thrombus[J].Ann Surg Oncol,2010,17(8):2073-2080.
|
|
[14] SHI J,LAI E,LI N,et al.A new classification for hepatocellular carcinoma with portal vein tumor thrombus[J].J Hepatobiliary Pancreat Sci,2011,18(1):74-80.
|
|
[15]EDGE SB,BYRD DR,COMPTON CC,et al.AJCC cancer staging manual[M].7th ed.New York:Springer,2010:191-200.
|
|
[16]GRAF D,VALLBHMER D,KNOEFEL WT,et al.Multimodal treatment of hepatocellular carcinoma[J].Eur JIntern Med,2014,25:430-437.
|
|
[17]Ministry of Health of the Peoples Republic of China.Diagnosis,management and treatment of hepatocellular carcinoma(2011 version)[J].J Clin Hepatol,2011,27(11):1141-1159.(in Chinese)中华人民共和国卫生部.原发性肝癌诊疗规范(2011年版)[J].临床肝胆病杂志,2011,27(11):1141-1159.
|
|
[18]SCHWARZ RE,ABOU-ALFA GK,GESCHWIND JF,et al.Nonoperative therapies for combined modality treatment of hepatocellular cancer:expert consensus statement[J].HPB(Oxford),2010,12(5):313-320.
|
|
[19]PAUL SB,SHARMA H.Role of transcatheter intra-arterial therapies for hepatocellular carcinoma[J].J Clin Expheatol,2014,4(Suppl 3):s112-s121.
|
|
[20]BAEK YH,KIM KT,LEE SW,et al.Efficacy of hepatic arterial infusion chemotherapy in advanced hepatocellular carcinoma[J].World J Gastroenterol,2012,18(26):3426-3434.
|
|
[21]IKEDA M,OKUSAKA T,FURUSE J,et al.A multi-institutional phase II trial of hepatic arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma with portal vein tumor thrombosis[J].Cancer Chemother Pharmacol,2013,72(2):463-470.
|
|
[22]KASAI K,USHIO A,KASAI Y,et al.Therapeutic efficacy of combination therapy with intra-arterial 5-fluorouracil and systemic pegylated interferon a-2b for advanced hepatocellular carcinoma with portal venous invasion[J].Cancer,2012,118:3302-3310.
|
|
[23]SON DS,BAE SH,SONG MJ,et al.Hepatic arterial infusion chemotherapy in hepatocellular carcinoma with portal vein tumor thrombosisa[J].World J Gastroenterol,2013,19(29):4679-4688.
|
|
[24]CHUNG YH,SONG H,SONG CB,et al.Combined therapy consisting of intraarterial cisplatin infusion and systemic interferon-a for hepatocellular carcinoma patients with major portal vein thrombosis or distant metastasis[J].Cancer,2000,88:1986-1991.
|
|
[25]NAGANO H,KOBAYASHI S,MARUBASHI S,et al.Combined IFN-αand 5-FU treatment as a postoperative adjuvant following surgery for hepatocellular carcinoma with portal venous tumor thrombu[J].Exp Ther Med,2013,5(1):3-10.
|
|
[26] European Association For the Study of Liver,European Organisation for Research and Treatment of Cancer.EASL-EORTC clinical practice guidelines:management of hepatocellular carcinoma[J].J Hepatol,2012,56(4):908-943.
|
|
[27]NIU ZJ,MA YL,KANG P,et al.Transarterial chemoembolization compared with conservative treatment for advanced hepatocellular carcinoma with portal vein tumor thrombus:using a new classification[J].Med Oncol,2012,29(4):2992-2997.
|
|
[28]LUO J,GUO RP,LAI ECH,et al.Transarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein tumor thrombosis:a prospective comparative study[J].Ann Surg Oncol,2011,18(2):413-420.
|
|
[29]YE JZ,ZHANG YQ,YE HH,et al.Appropriate treatment strategies improve survival of hepatocellular carcinoma patients with portal vein tumor thrombus[J].World J Gastroenterol,2014,20(45):17141-17147.
|
|
[30]ZHOU Q,WANG Y,ZHOU X,et al.Prognostic analysis for treatment modalities in hepatocellular carcinomas with portal vein tumor thrombi[J].Asian Pac J Cancer Prev,2011,12(11):2847-2850.
|
|
[31]CHUNG GE,LEE JH,KIM HY.Transarterial chemoembolization can be safely performed in patients with hepatocellular carcinoma invading the main portal vein and may improve the overall survival[J].Radiology,2011,258(2):627-634.
|
|
[32]LENG JJ,XU YZ,DONG JH.Efficacy of transarterial chemoembolization for hepatocellular carcinoma with portal vein thrombosis:a meta-analysis[J].ANZ J Surg,2014.[Epub ahead of print]
|
|
[33]ZHAO Y,CAI GH,ZHOU L,et al.Transarterial chemoembolization in hepatocellular carcinoma with vascular invasion or extrahepatic metastasis:a systematic review[J].Asia Pac J Clin Onco,2013,9(4):357-364.
|
|
[34]NOVI M,LAURITANO EC,PISCAGLIA AC,et al.Portal vein tumor thrombasis revascularization during sorafenib treatment for hepatocellular carcinorna[J].Arn J Gastroenterol,2009,104(7):1852-1854.
|
|
[35]QU XD,CHEN CS,WANG JH,et al.The efficacy of TACE combined sorafenib in advanced stages hepatocellullar carcinoma[J].BMC Cancer,2012,12:263.
|
|
[36]ZHU K,CHEN J,LAI L,et al.Hepatocellular carcinoma with portal vein tumor thrombus:treatment with transarterial chemoembolization combined with sorafenib-a retrospective controlled study[J].Radiology,2014,272(1):284-293.
|
|
[37]BAI W,WANG YJ,ZHAO Y,et al.Sorafenib in combination with transarterial chemoembolization improves survival of unresectablehepatocellular carcinoma:a propensity score matching study[J].J Dig Dis,2013,14(4):181-190.
|
|
[38]TAN WF,QIU ZQ,YU Y,et al.Sorafenib extends the survival time of patients with multiple recurrences of hepatocellular carcinoma after liver transplantation[J].Acta Pharmacol Sin,2010,31(12):1643-1648.
|
|
[39] CHEN JW,PANG PF,MENG XC,et al.Clinical observation of transcatheter arterial chemoembolization plus sorafenib in the treatment of advanced hepatocellular carcinoma with different types of portal vein tumor thrombosis[J].Natl Med J China,2013,93(9):663-667.(in Chinese)陈俊伟,庞鹏飞,孟晓春,等.TACE联合索拉非尼治疗原发性肝癌合并同分型门静脉癌栓的临床观察[J].中华医学杂志,2013,93(9):663-667.
|
|
[40]PAN T,LI XS,XIE QK,et al.Safety and efficacy of transarterial chemoembolization plus sorafenib for hepatocellular carcinoma with portal venous tumour thrombus[J].Clin Radiol,2014,69(12):553-561.
|
|
[41]PARK JW,KOH YH,KIM HB,et al.Phase II study of concurrent transarterial chemoembolization and sorafenib for patients with unresectable hepatocellular carcinoma[J].J Hepatol,2012,56(6):1336-1342.
|
|
[42]CHAOY,CHUNG YH,HAN GH,et al.The combination of transcatheter arterial chemoembolization and sorafenib is well tolerated and effective in Asian patients with hepatocellular carcinoma:final results of the START trial[J].Int J Cancer,2015,136(6):1458-1467.
|
|
[43]ZHENG JS,LONG J,SUN B,et al.Transcatheter arterial chemoembolization combined with radiofrequency ablation can improve survival of patients with hepatocellular carcinoma with portal vein tumour thrombosis:Extending the indication for ablation?[J].Clin Radiol,2014,69(6):e253-e263.
|
|
[44]BECKER G,SOEZGEN T,OLSCHEWSKI M,et al.Combined TACE and PET for palliative treatment of unresectable hepatocellular carcinoma[J].World J Gastoentero,2005,11(39):6104-6109.
|
|
[45]LI C,ZHANG W,ZHANG R,et al.Therapeutic effects and prognostic factors in high—intensity focused ultrasound combined with chemoembolisation for larger hepatocellular carcinoma[J].Eur J Cancer,2010,46(13):2513-2521.
|
|
[46]ARIENTI V,PRETOLANI S,PACELLA CM,et al.Complications of laser ablation for hepatocellular carcinoma:a multicenter study[J].Radiology,2008,246(3):947-955.
|
|
[47]LIANG LJ,HU WJ,YIN XY,et al.Adjuvant intraportal venous chemotherapy for patients with hepatocellular carcinoma and portal vein tumor thrombi following hepatectomy plus portal thrombectomy[J].World J Surg,2008,32(4):627-631.
|
|
[48]CHUAN-XING L,XU H,BAO-SHAN H,et al.Efficacy of therapy for hepatocellular carcinoma with portal vein tumor thrombus Chemoembolization and stent combined with iodine-125 seed[J].Cancer Biol Ther,2011,12(10):865-871.
|
|
[49]ZHANG L,LU LG,LI Y,et al.Portal vein stent placement combined with TACE for the treatment of hepatocellular carcinoma associated with tumor thrombus in portal vein[J].J Intervent Radiol,2011,20(12):968-973.(in Chinese)张磊,陆骊工,李勇,等.门静脉支架联合肝动脉化疗栓塞治疗肝癌伴门静脉癌栓的临床研究[J].介入放射学杂志,2011,20(12):968-973.
|
|
[50]YOON SM,LIM YS,WON HJ,et al.Radiotherapy plus transarterial chemoembolization for hepatocellular carcinoma invading the potal vein:long-term putcomes[J].Int J Radiat Oncol Biol Phys,2012,82(5):2004-2011.
|
|
[51]FUJINO H,KIMURA T,AIKATA H,et al.Role of 3-D conformal radiotherapy for major portal vein tumor thrombosis combined with hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma[J].Hepatol Res,2014.[Epub ahead of print]
|
|
[52]TANG QH,LI AJ,YANG GM,et al.Surgical resection versus conformal radiotherapy combined with tace for resectable hepatocellular carcinoma with portal vein tumor thrombus:a comparative study[J].World J Surg,2013,37(6):1362-1370.
|
|
[53]PRACHT M,EDELINE J,LENOIR L,et al.Lobar hepatocellular carcinoma with ipsilateral portal vein tumor thrombosis treated with yttrium-90 glass microsphere radioembolization:preliminary results[J].Int J Hepatol,2013,2013:827649.
|
|
[54]IKAI I,HATANO E,HASEGAWA S,et al.Prognostic index for patients with hepatocellular carcinoma combined with tumor thrombosis in the major portal vein[J].J Am Coll Surg,2006,202(3):431-438.
|
|
[55]JIA L,KIRYU S,WATADANI T,et al.Prognosis of hepatocellular carcinoma with portal vein tumor thrombus:assessment based on clinical and computer tomography characteristics[J].Acat Med Okayma,2012,66(2):131-141.
|
|
[56]CHEN JS,WANG Q,CHEN XL,et al.Clinicopathologic characteristics and surgical outcomes of hepatocellular carcinoma with portal vein tumor thrombosis[J].J Surg Res,2012,175(2):243-250.
|
DownLoad: